Ortin Laboratories Ltd

Ortin Global Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's code of conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. A board meeting will be convened to consider and approve these financial results, with a separate intimation to be sent to the stock exchange regarding the meeting notice.

Rarever Financial Advisors Private Limited, acting as the Manager to the Offer, has submitted a Pre-Offer Advertisement cum Corrigendum to the public announcement to the BSE. This filing pertains to an ongoing offer process, with further details expected in the detailed public announcement. Investors should refer to the official filings for comprehensive information regarding the offer.

Ortin Global Limited (formerly Ortin Laboratories Limited) announced audited financial results for the quarter and year ended March 31, 2026. The company reported a net loss before tax of ₹72.34 lakhs for the year ended March 31, 2026, compared to a loss of ₹83.75 lakhs in the previous year. Total income for the year stood at ₹4150 lakhs, compared to ₹3835 lakhs in the previous year. The Board of Directors approved the results in a meeting held on May 30, 2026.

Ortin Global Limited's board meeting on May 30, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The meeting, held at the company's registered office in Hyderabad, also included the approval of the Auditor’s Report along with the declaration as per Regulation 33 of SEBI (LODR) Regulations, 2015.

Ortin Global Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited standalone financial results along with the Auditor’s Report for the quarter and year ended March 31, 2026. The trading window is closed from April 1, 2026, until 48 hours after the declaration of the audited financial results.

Rarever Financial Advisors Pvt. Ltd., the manager to the open offer for Ortin Global Ltd, has announced that the identified date for determining the shareholders to whom the Letter of Offer will be sent is fixed as May 21, 2026. This is in compliance with Regulation 18(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Ortin Global Ltd (formerly Ortin Laboratories Limited) has announced the closure of the trading window for all designated persons, their immediate relatives, and connected persons. The closure is in accordance with the Company's Code of Conduct for Prevention of Insider Trading under SEBI regulations. The trading window will remain closed from 01.04.2026 until 48 hours after the declaration of audited Financial Results for the quarter and financial year ended 31.03.2026. The Board Meeting is scheduled to consider and approve the audited Financial Results for the quarter and year ended March 31, 2026. An intimation regarding the notice of the Board Meeting will be sent separately to the Stock Exchanges.

Ortin Global Ltd has received a disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Suresh Gadalay. Gadalay, along with his wife Kamal Gadalay and son Aditya Gadalay, has acquired 31,640 shares of the company on 23rd February 2026, resulting in the shareholding reaching the threshold limit of 5% of the paid-up share capital of the company. The total equity share capital of the company is 8,13,13,920 divided into 81,31,392 equity shares of Rs. 10/- each. The total diluted share/voting capital of the company after the acquisition is also 8,13,13,920 divided into 81,31,392 equity shares of Rs. 10/- each.

Parveen Satija, an Indian business professional with over 20 years of experience, has agreed to acquire 26% of the voting equity share capital of Ortin Global Ltd from the promoters. The acquisition will be made at a price of INR 14.65 per share, amounting to INR 3.09 crores. Satija does not have any relationship or interest in the Target Company, except for the contractual arrangement in relation to the Underlying Transaction. He confirms that there is no person acting in concert with him in relation to this Offer. The acquisition is in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ortin Global Ltd, formerly known as Ortin Laboratories Limited, announced its unaudited financial results for the quarter and year ended 31.12.2025 during a Board Meeting held on 14.02.2026. The company reported a net loss of ₹ 85.67 lakhs for the quarter and ₹ 68.23 lakhs for the year. The meeting was held at the company's registered office in Hyderabad.